Innovative Technologies Designed to Enhance the Detection and Monitoring of Ocular Disease
AdaptDx Pro®
The Power of Functional Retinal Testing with AdaptDx Pro
AdaptDx Pro is a wearable dark adaptometer that leverages AI to ensure a consistent patient experience. Impaired dark adaptation speed, a key early indicator of rod-mediated dysfunction, is often among the first functional signs of retinal disease.
Dark Adaptation: A Critical Function of Retinal Health
Dark adaptation is the process of the eyes adjusting to low levels of illumination. Impaired dark adaptation speed indicates rod-mediated dysfunction, one of the first functional signs of retinal disease.
Rod-Mediated Dysfunction
Rod-mediated dysfunction refers to impairments in the function of rod photoreceptors, which are responsible for scotopic vision and play a critical role in dark adaptation.
AdaptDx Pro is available in the U.S.
Disclaimer: AdaptDx Pro has not been approved by FDA for use in detection or diagnosis of any specific ocular disease (such as AMD). The safety and effectiveness of AdaptDx Pro for this use has not been established.
NOVA™ Vision Testing System
The NOVA Vision Testing System analyzes the entire pathway for visual and neuro-visual disorders.
Visual Evoked Potential (VEP) is a non-invasive diagnostic test that measures the brain’s electrical response to visual stimuli. It evaluates the function of the visual pathways from the eyes to the visual cortex in the brain. During the test, visual stimuli—such as flashing lights or patterns—are presented to the patient while electrodes placed on the scalp detect neural activity.
Electroretinography (ERG) is a diagnostic test that measures the electrical activity of the retina in response to light stimuli. It assesses the function of the photoreceptors (rods and cones) and other retinal cells by detecting electrical signals generated when the retina processes light.
ERG is used to diagnose and monitor various retinal conditions, such as retinitis pigmentosa, age-related macular degeneration (AMD), and diabetic retinopathy.
NOVA VEP is available in the US. NOVA VEP and ERG are available in the EU and other select countries.